Company: MDCXW
Filing Date: 2025-05-27
Form Type: S-1
Source: 0001062993-25-010333
Chunk: 166

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-27
Form: S-1
Chunk 166
---
 equity compensation plans, the weighted-average exercise price of such outstanding convertible securities and the number of common shares remaining available for future issuance under equity compensation plans as at December 31, 2024.

| Plan Category                                              |         Number of common 
 shares to be issued upon 
  exercise of outstanding 
    Options, warrants and 
                   rights | Weighted-average     
 exercise price of    
 outstanding Options, 
 warrants and rights  |      Number of common 
      shares remaining 
  available for future 
 issuance under equity 
    compensation plans |
| Equity compensation plans approved by security holders     |                1,185,000 | C$2.06               |               801,556 |
| Equity compensation plans not approved by security holders |                        - | -                    |                     - |
| Total                                                      |                1,185,000 | C$2.06               |               801,556 |

<div align='center'>- 112 -

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth information regarding the beneficial ownership of our common shares as of May 21, by:

each person known by us to be the beneficial owner of more than 5% of our outstanding common shares;

each of our executive officers and directors; and

all our executive officers and directors as a group.

The number of shares beneficially owned by each shareholder is determined under rules issued by the SEC. Under these rules, beneficial ownership includes any shares as to which a person has sole or shared voting power or investment power. Applicable percentage ownership is based on 13,572,737 common shares outstanding as of May 21, 2025. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, common shares subject to options, warrants, or other rights held by such person that are currently exercisable or will become exercisable within 60 days of May 21, 2025 are considered outstanding, although these shares are not considered outstanding for purposes of computing the percentage ownership of any other person.

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all common shares beneficially owned by them.

| Name and Address of Beneficial Owner                       |     |    Number of 
       Shares 
 Beneficially 
        Owned |     |     | Approximate   
 Percentage of 
 Outstanding   
 Common Shares |
| Directors and Executive Officers of Medicus Pharma Ltd.(1) |     |